Alaway and Potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alaway (ketotifen fumarate) and Potassium (potassium). Common drug interactions include alopecia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Alaway and Potassium. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Alaway?

Alaway has active ingredients of ketotifen fumarate. eHealthMe is studying from 1,550 Alaway users. Check the latest studies of Alaway.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,148 Potassium users. Check the latest studies of Potassium.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

18 people who take Alaway and Potassium together, and have interactions are studied.

What are the common drug interactions of Alaway and Potassium, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Anaemia (lack of blood)
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
Cardiac disorder
Contusion (a type of hematoma of tissue in which capillaries)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dyspnoea (difficult or laboured respiration)
Fibromyalgia (a long-term condition which causes pain all over the body)
Gingival bleeding (bleeding gums)
Haemorrhage (bleeding)

male:

Fatigue (feeling of tiredness)
Headache (pain in head)
Insomnia (sleeplessness)
Localised infection (infection at the single location)
Oedema peripheral (superficial swelling)
Pain in extremity

What are the common drug interactions of Alaway and Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Alopecia (absence of hair from areas of the body)
Fatigue (feeling of tiredness)
Fibromyalgia (a long-term condition which causes pain all over the body)
Visual impairment
Hot flush (sudden feelings of heat)
Neoplasm progression (growth of tumour)

50-59:

Diarrhoea

60+:

Eye irritation
Fatigue (feeling of tiredness)
Anaemia (lack of blood)
Dyspnoea (difficult or laboured respiration)
Eye swelling
Headache (pain in head)
Injection site pain
Insomnia (sleeplessness)
Localised infection (infection at the single location)
Neutropenia (an abnormally low number of neutrophils)

What are the existing conditions these people have? *

Hypersensitivity: 4 people, 22.22%
Pain: 3 people, 16.67%
Diarrhea: 3 people, 16.67%
Dry Eyes (lack of adequate tears): 3 people, 16.67%
Breast Cancer Female: 2 people, 11.11%
Colon Cancer: 2 people, 11.11%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 11.11%
Insomnia (sleeplessness): 2 people, 11.11%
Eye Pruritus (eye itching): 2 people, 11.11%
Urinary Tract Infection: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Alaway and Potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously